The world of regulatory compliance is constantly evolving, and the use of electronic regulatory artwork submissions (eRAS) has emerged as a transformative tool. eRAS offer a streamlined and efficient way to submit regulatory artwork, and it provides a host of benefits for both regulators and submitters.
Sustaining the ever-evolving global Regulatory space of the life sciences industry is strenuous. Therefore, it is necessary for manufacturers to keep abreast with the latest Regulatory information to ensure compliance across all the business functions, such as clinical development, release, and marketing scrutiny of medicines.
Wide range of food products, dietary supplements and other health foods that are consumed to enhance the nutritional value of food are constantly growing, worldwide. All combined can generally be termed as nutraceuticals. Global consumers are viewing the nutraceutical products as potential alternatives to medicinal products owing to their preventive characteristics against some of the common lifestyle diseases.
Packaging, labeling and “artwork” are crucial stages of a drug product lifecycle, as they are the main safety information sources for the end user. Any mislead in these processes may lead to product recalls. Hence, it is highly important for a manufacturer to contemplate all possible approaches to successfully implement them either in-house or by opting managed services i.e. to contract out. While some companies contract the complete artwork process, others prefer to keep it in-house for confidentiality reasons.